Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss DNLI - Denali Therapeutics Inc.
643 K
LAST VALUE
50.24%
2 YEAR CAGR
24.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR